QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
Latest Information Update: 12 Oct 2023
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms QUICK-CURE
- 06 Oct 2023 Status changed from recruiting to completed.
- 10 May 2021 Status changed from not yet recruiting to recruiting.
- 10 Mar 2021 Planned initiation date changed from 1 Mar 2021 to 1 Apr 2021.